***********************************
Brakke Consulting’s
Animal Health News & Notes for March 6, 2026
Copyright © Brakke Consulting
Editor: Christine Merle DVM, MBA, CVPM
************************************
IN THE NEWS:
Brakke Consulting News
Brakke Search is Hiring
Earning News
CVS Group (UK)
ImmuCell
Company News
AHV International
Akston
Blue-9
Elanco
Future Pak
Gallant
Innocan Pharma
Jaguar
Lyka (AU)
Mars
MWI Animal Health
Neogen
Paw Prosper
Symbiotic Capital
TARGAN
Tractor Supply
ValiRx
VievePharm (EU)
Zenex Animal Health (EU)
Zoetis
Animal Health News
European Union
United Kingdom
United States
***********************************
Company Earnings Releases
- Immucell shared its unaudited financial results for the full year 2025, highlighting a net operating income of $1.6M with product sales increasing by 4.3%. (company press release)
- UK-CVS Group published their interim results for the 6 months ending December 31, 2025, showing operating revenues increasing by 5.8% to £356.9M (US$477.3M) and operating profits dropping by 11.2% to £22.1M (US$29.56M). (com)
***********************************
Brakke Search
QA Career Opportunity

Are you a QA leader with FDA and/or USDA experience or do you know someone who is? Do you flourish in a small, informal environment where you roll up your sleeves on groundbreaking new projects in a brand new, state of the art facility? Would you like to join an up-and-coming company that offers a competitive compensation package including equity, and a comfortable but focused work environment? If so, we’d like to talk to you! Our client is hiring now.
This is an onsite position located in Shreveport, LA, a great way to make an impact in the company and industry. For more information, contact Jeff Santosuosso.
*********************************************
Company News Releases
- Zoetis announced the acquisition ofNeogen’s Animal Genomics Business for $160M, expanding its capabilities in livestock genomics. (company press release)
- Elanco announced during their 2025 earnings call that they had signed an agreement to acquireAHV International, a Dutch based dairy health (agrinovusindiana.com)
- Gallantand MWI Animal Health announced the creation of the first-ever ultra-low temperature cold chain fulfillment agreement allowing for nationwide availability of the reliable delivery of veterinary stem cell therapies. (company press release)
- Marsannounced the launch of a new enterprise-level philanthropic entity, the Mars Impact Fund, designed to impact the communities where Mars operates. (company press release)
- Akston’sopened its manufacturing facility in Shreveport, LA and commercial manufacturing operations are set to begin in a few months. (gov)
- TARGAN, an animal health and AgTechcompany, announced a $100M financing agreement with Symbiotic Capital to support growth and commercialization of its WingScan (wattagnet.com)
- Jaguarhas terminated its buy-back provision of the US licensing agreement with Future Pak and per the agreement received a $3 million payment. (company press release)
- InnocanPharma has received its third consecutive fee waiver from the FDA’s CVM for its animal drug application. (yahoo.com)
- ValiRxestablished a wholly owned subsidiary, ValiRx Animal Health Ltd, to develop and commercialize its oncology assets within the veterinary market. (co.uk)
- Tractor Supply’ssubsidiaries Petsense and Allivet, have formed its Pet Expert Advisory Council, a cross-species veterinary advisory group that encompasses retail and digital pharmacy. (com)
- Paw Prosper, an animal health and wellness platform, has acquiredBlue-9, an innovator in behavior pet products. The combined family of brands provides a single source for tools and courses in fitness training and conditioning for pets. (com)
- AU-Lyka, an Australian based fresh food company, has raised $67M (US$4M) in a Series C funding round led by US investors that will fund global expansion and clinical research. (smartcompany.com.au)
- EU- ZenexAnimal Health, an India-based animal health company, acquired VievePharm, a Netherlands- based natural nutrition specialist, establishing an expansion into Western Europe. (company press release)
***********************************
Animal Health Stock Price Tracker

***********************************
Animal Health News
- US- FEDERAL STUDENT LOAN LIMITS- Starting July 1, students entering professional school (including medicine, dentistry, law and veterinary) will have their federal loans capped at a maximum program limit of$200,000 potentially impacting the four out of five veterinary students that borrow money for their veterinary education. (vin.com)
- US-MURRAY STATE UNIVERSITY- A new College of Veterinary Medicine was voted on by the Board of Regents and will now seek accreditation from the AVMA. (com)
- US- REGENERATIVE MEDICINE- A new surveyon regenerative medicine conducted by the American Animal Hospital Association in collaboration with Gallant was released. (com)
- EU- TUMOR DATABASE- Researchers at University of Liverpool and University of Las Palmas de Gran have created the world’s largest open-source database containing over one million records of canine and feline tumors. (org)
- UK-ANIMAL OFFENDER REGISTRY- The Scottish Society for the Prevention of the Cruelty to Animals has asked for the introduction of a national animal offenders register. (co.uk)
- UK-CHRONIC KIDNEY DISEASE- A recently published studyfrom the University of Nottingham showing domestic cat kidneys accumulate unusual fats even at a young age making them prone to chronic kidney disease. (ac.uk)
- UK- NEUTERING DOGS- A newly published policy documentfrom BVA and BSAVA urges that neutering of dogs needs more comprehensive research. (com)
************************************
Brakke Consulting Viewpoint
It was my pleasure this week to join my Brakke colleagues and many global animal health industry leaders in London for Kisaco’s Animal Health & Nutrition Technology and Innovation Conference.
The quality and quantity of presentations and conversations highlighted the strength of the animal health industry and its many innovation opportunities ahead.
A particularly refreshing presentation was a conversation facilitated by Kristin Peck, CEO of Zoetis, and Dr. Timothy Shell, Director of the FDA’s Center for Veterinary Medicine (CVM). Dr. Shell shared his vision for reforming the CVM’s animal health approval process, noting that FDA interactions will play a key role in determining how future innovations reach the market.
He touched on several proposed changes—cautioning these are not formal guidance and likely require 3–5 years to implement:
- Reducing average approval time from 10 years to 5 years
- Tripling MUMS approvals from 2 to 6 per year, with a voucher program for expedited review
- Extending conditional approval from 5 to 7 years for chronic diseases and including the CMC section
- Updating the user fee program to enable shorter reviews with applicable fees
- Evolving residue and toxicology regulations
- Leveraging foreign agency data and approvals, while addressing regulatory gaps within set timelines
- Utilizing AI to accelerate administrative processes
In closing, Dr. Shell stated that the CVM is evolving and encouraged companies never to pause or delay projects without first consulting the agency. This collaboration will support the timely introduction of valuable animal health products for pets and livestock.
Chuck Johnson DVM, MBA
***********************************
Your View
Last week we asked you to tell us what “too much” for your own pets’ annual wellness veterinary visit might be including any vaccines, wellness tests and preventatives. Of those that owned pets, 44% chose $501-$750, 34% were at $251-$500, 19% came in at $751-$1,000 and 3% were at $100-$250. Below is a chart using average cost data for a 45 lb. dog’s annual wellness veterinary visit, looks like 81% of us are already beyond our own personal “too much”.

For this week’s question, Chuck’s viewpoint mentioned a willingness by the FDA’s CVM to reform its review processes, including streamlining and accelerating its procedures. How likely do you think the CVM will have meaningful and significant reforms by 2031?